Transcripts
BridgeBio Pharma (BBIO) earnings call transcripts
Earnings call transcripts for BridgeBio Pharma, Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed BridgeBio as entering a multi-launch chapter, with stronger ATTR differentiation, three regulatory reviews, and profitability approaching.
Aug 10, 2026Confident0.83